Drug Shortage Report for MAXIDEX

Last updated on 2019-12-02 History
Report ID 97281
Drug Identification Number 00042560
Brand name MAXIDEX
Common or Proper name MAXIDEX 0.1% SUSP 5ML
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Active Ingredient(s) DEXAMETHASONE
Strength(s) 0.1%
Dosage form(s) SUSPENSION
Route of administration OPHTHALMIC
Packaging size 5ML
ATC code S01BA
ATC description ANTIINFLAMMATORY AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2019-10-23
Estimated end date 2020-03-31
Actual end date
Shortage status Actual shortage
Updated date 2019-12-02
Company comments Supply interruption
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-10-25 English Compare
v2 2019-10-25 English Compare
v3 2019-10-25 French Compare
v4 2019-10-25 French Compare
v5 2019-10-25 English Compare
v6 2019-10-25 French Compare
v7 2019-12-02 English Compare
v8 2019-12-02 French Compare